{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:47:58Z","timestamp":1776872878787,"version":"3.51.2"},"reference-count":23,"publisher":"Scientific Scholar","content-domain":{"domain":["indianjnephrol.org"],"crossmark-restriction":true},"short-container-title":["IJN"],"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Neural epidermal-like growth factor-like 1 (NELL-1) is a protein kinase C binding protein expressed in osteoblasts and renal tubules. It is expressed in 5%\u201325% glomerular cells at the mRNA level. Membranous Nephropathy (MN) is characterized by the presence of antibodies against certain types of antigens on the glomerular basement membrane. The most common one implicated in primary MN is an antibody against PLA2R. Many newer antigens have been discovered in the recent past, which are proven to cause secondary MN, one of which is NELL-1. NELL-1 has been associated with malignancy-associated MN and also recently associated with traditional indigenous medications containing mercury. In this study, we study the expression of NELL-1 in mercury-associated MN.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Materials and Methods:<\/jats:title>\n<jats:p>Records of ten cases of Mercury -associated MN were retrieved from the Institute medical archives and NELL-1 Immunohistochemistry was performed in all ten cases.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>NELL-1 was found to be positive in 50% of the cases of Mercury associated MN. In addition, mass spectrometric studies was performed, which revealed the common Mercuric compound associated to be \u2018Swaskalpa\u2019, \u2018Sudarshana Melugu\u2019 and \u2018Rasagandhi Mezhugu\u2019.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This study highlights why it is important to diagnose mercury-associated MN by a pathologist by picking up the finer histopathological clues and by using NELL-1 immunohistochemistry, especially in PLA2R-negative patients. The former is true as most of the time a history of mercuric compound intake is missed out.<\/jats:p><\/jats:sec>","DOI":"10.25259\/ijn_109_2024","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T10:25:27Z","timestamp":1716200727000},"page":"482-486","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nerve Epidermal Growth Factor-Like 1 Protein (NELL-1) Expression in Mercury-Related Membranous Nephropathy: Is It a True Association or a Chance Occurrence?"],"prefix":"10.25259","volume":"34","author":[{"given":"Bheemanathi Hanuman","family":"Srinivas","sequence":"first","affiliation":[{"name":"Department of Pathology, JIPMER, Puducherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norton","family":"Stephen","sequence":"additional","affiliation":[{"name":"Department of Pathology, All India Institute of Medical Sciences (AIIMS), Madurai, Puducherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PS","family":"Priyamvada","sequence":"additional","affiliation":[{"name":"Department of Nephrology, JIPMER, Puducherry, India,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh Nachiappa","family":"Ganesh","sequence":"additional","affiliation":[{"name":"Department of Pathology, JIPMER, Puducherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreejith","family":"Parameswaran","sequence":"additional","affiliation":[{"name":"Department of Nephrology, JIPMER, Puducherry, India,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debasis","family":"Gochhait","sequence":"additional","affiliation":[{"name":"Department of Pathology, JIPMER, Puducherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2024,5,20]]},"reference":[{"key":"10.25259\/IJN_109_2024\/ref-1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1681\/ASN.2020071082","article-title":"New \u2018Antigens\u2019 in membranous nephropathy","volume":"32","author":"Sethi","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.25259\/IJN_109_2024\/ref-2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1006\/bbrc.1999.1638","article-title":"Biochemical characterization and expression analysis of neural thrombospondin-1-like proteins NELL1 and NELL2","volume":"265","author":"Kuroda","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.25259\/IJN_109_2024\/ref-3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12033-011-9440-4","article-title":"Efficient production and characterization of recombinant human NELL1 protein in human embryonic kidney 293-F cells","volume":"51","author":"Hasebe","year":"2012","journal-title":"Mol Biotechnol"},{"key":"10.25259\/IJN_109_2024\/ref-4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"10.25259\/IJN_109_2024\/ref-5","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"key":"10.25259\/IJN_109_2024\/ref-6","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1681\/ASN.2018080852","article-title":"Exostosin 1\/exostosin 2-associated membranous nephropathy","volume":"30","author":"Sethi","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.25259\/IJN_109_2024\/ref-7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.kint.2019.09.014","article-title":"Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy","volume":"97","author":"Sethi","year":"2020","journal-title":"Kidney Int"},{"key":"10.25259\/IJN_109_2024\/ref-9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.kint.2019.09.014","article-title":"Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy","volume":"97","author":"Sethi","year":"2020","journal-title":"Kidney Int"},{"key":"10.25259\/IJN_109_2024\/ref-10","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1038\/s41598-022-07037-2","article-title":"Prevalence of neural epidermal growth factor-like 1- and exostosin 1\/exostosin 2- associated membranous nephropathy: a single-center retrospective study in Japan","volume":"12","author":"Iwakura","year":"2022","journal-title":"Sci Rep"},{"key":"10.25259\/IJN_109_2024\/ref-11","doi-asserted-by":"publisher","first-page":"807807","DOI":"10.3389\/fphar.2022.807807","article-title":"Mercury and mercury-containing preparations: History of use, clinical applications, pharmacology, toxicology, and pharmacokinetics in traditional chinese medicine","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.25259\/IJN_109_2024\/ref-12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.kint.2019.09.014","article-title":"Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy","volume":"97","author":"Sethi","year":"2020","journal-title":"Kidney Int"},{"key":"10.25259\/IJN_109_2024\/ref-13","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3390\/ijms18051039","article-title":"Chronic kidney disease and exposure to nephrotoxic metals","volume":"18","author":"Orr","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.25259\/IJN_109_2024\/ref-14","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.ekir.2022.04.078","article-title":"What can mercury teach us about membranous nephropathy and minimal change disease?","volume":"7","author":"Caza","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.25259\/IJN_109_2024\/ref-15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000510877","article-title":"Unveiling the features of mercury-associated minimal change disease: Comparison with primary minimal change disease","volume":"7","author":"Qin","year":"2021","journal-title":"Kidney Dis (Basel)"},{"key":"10.25259\/IJN_109_2024\/ref-16","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.ekir.2022.03.009","article-title":"Toxic nephropathy secondary to chronic mercury poisoning: clinical characteristics and outcomes","volume":"7","author":"Gao","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.25259\/IJN_109_2024\/ref-17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12882-019-1413-z","article-title":"Mercury-associated glomerulonephritis:A retrospective study of 35 cases in a single Chinese center","volume":"20","author":"Qin","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.25259\/IJN_109_2024\/ref-18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2215\/CJN.07571009","article-title":"Mercury induced membranous nephropathy: clinical and pathological features","volume":"5","author":"Li","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.25259\/IJN_109_2024\/ref-19","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.kint.2021.10.010","article-title":"Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)-associated membranous nephropathy","volume":"100","author":"Spain","year":"2021","journal-title":"Kidney Int"},{"key":"10.25259\/IJN_109_2024\/ref-20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1177\/0022034510376401","article-title":"The role of NELL-1, a growth factor associated with craniosynostosis, in promoting bone regeneration","volume":"89","author":"Zhang","year":"2010","journal-title":"J Dent Res"},{"key":"10.25259\/IJN_109_2024\/ref-21","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/ckj\/sfac237","article-title":"The many faces of NELL1 MN","volume":"16","author":"Sethi","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.25259\/IJN_109_2024\/ref-22","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.kint.2022.09.001","article-title":"Traditional indigenous medicines are an etiologic consideration for NELL1-positive membranous nephropathy","volume":"102","author":"Kurien","year":"2022","journal-title":"Kidney Int"},{"key":"10.25259\/IJN_109_2024\/ref-23","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2215\/CJN.11860720","article-title":"Neural epidermal growth factor-like 1 protein-positive membranous nephropathy in Chinese patients","volume":"16","author":"Wang","year":"2021","journal-title":"Clinical Journal of the American Society of Nephrology (CJASN)"},{"key":"10.25259\/IJN_109_2024\/ref-24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2215\/CJN.07571009","article-title":"Mercury-induced membranous nephropathy: Clinical and pathological features","volume":"5","author":"Li","year":"2010","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/indianjnephrol.org\/nerve-epidermal-growth-factor-like-1-protein-nell-1-expression-in-mercury-related-membranous-nephropathy-is-it-a-true-association-or-a-chance-occurrence\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/indianjnephrol.org\/nerve-epidermal-growth-factor-like-1-protein-nell-1-expression-in-mercury-related-membranous-nephropathy-is-it-a-true-association-or-a-chance-occurrence\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T12:11:27Z","timestamp":1725019887000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/nerve-epidermal-growth-factor-like-1-protein-nell-1-expression-in-mercury-related-membranous-nephropathy-is-it-a-true-association-or-a-chance-occurrence\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":23,"alternative-id":["10.25259\/IJN_109_2024"],"URL":"https:\/\/doi.org\/10.25259\/ijn_109_2024","relation":{},"ISSN":["1998-3662","0971-4065"],"issn-type":[{"value":"1998-3662","type":"electronic"},{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,20]]},"article-number":"482"}}